Integration and analysis of genome-scale data from gliomas. (Q33950522)

PubMed publication ID

30 July 2017

1 reference

title

Integration and analysis of genome-scale data from gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

14 May 2020

author name string

Gregory Riddick

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

14 May 2020

Howard A Fine

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

14 May 2020

language of work or name

English

0 references

publication date

5 July 2011

1 reference

PubMed publication ID

21727940

30 July 2017

published in

Nature Reviews Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

14 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

14 May 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

14 May 2020

page(s)

439-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

Advances in the genetics of glioblastoma: are we reaching critical mass?

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Neuro-oncology: unmasking the multiforme in glioblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Molecular epigenetics and genetics in neuro-oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Mining gene expression profiles: expression signatures as cancer phenotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Gene-Expression Profiles in Hereditary Breast Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Distinct transcription profiles of primary and secondary glioblastoma subgroups.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Identification of molecular subtypes of glioblastoma by gene expression profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Gene expression profiling identifies molecular subtypes of gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Gene expression profiling of gliomas strongly predicts survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Primary glioblastomas express mesenchymal stem-like properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Exploratory analysis of the copy number alterations in glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

A network model of a cooperative genetic landscape in brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Genome-wide association study identifies five susceptibility loci for glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Allelic Selection of Amplicons in Glioblastoma Revealed by Combining Somatic and Germline Analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Potential role of miRNAs and their inhibitors in glioma treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

The Many Functions of MicroRNAs in Glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: Role in the physiopathology of the disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

MicroRNAs and glioblastoma; the stem cell connection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

The many roles of microRNAs in brain tumor biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Prediction of Associations between microRNAs and Gene Expression in Glioma Biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

TP53 promoter methylation in human gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

PTEN methylation and expression in glioblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Frequent epigenetic inactivation of the SLIT2 gene in gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Molecular profiling in glioblastoma: prelude to personalized treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Glioma proteomics: status and perspectives.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Glioma pathophysiology: insights emerging from proteomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

An integrated genomic analysis of human glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Automated network analysis identifies core pathways in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Revealing targeted therapy for human cancer by gene module maps.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

A novel algorithm for detecting differentially regulated paths based on gene set enrichment analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

The transcriptional network for mesenchymal transformation of brain tumours.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

FastMEDUSA: a parallelized tool to infer gene regulatory networks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

An integrative approach for in silico glioma research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Rembrandt: helping personalized medicine become a reality through integrative translational research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

The Functional Genomics Experiment model (FuGE): an extensible framework for standards in functional genomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Exposing the cancer genome atlas as a SPARQL endpoint

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Online resources of cancer data: barriers, benefits and lessons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

A network view of disease and compound screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

A multigene predictor of outcome in glioblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Chemosensitivity prediction by transcriptional profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Predicting in vitro drug sensitivity using Random Forests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Utilization of genomic signatures to identify phenotype-specific drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Models from experiments: combinatorial drug perturbations of cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Gene expression patterns within cell lines are predictive of chemosensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Why is cancer drug discovery so difficult?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

Decoding global gene expression programs in liver cancer by noninvasive imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.100

microRNA-451: A conditional switch controlling glioma cell proliferation and migration.

31 March 2020

1 reference

12 December 2020

Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology

1 reference

12 December 2020

The Cancer Biomedical Informatics Grid (caBIG<sup>TM</sup>).

1 reference

12 December 2020

Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.

1 reference

12 December 2020

Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.

1 reference

12 December 2020

A genetically tractable model of human glioma formation.

1 reference

12 December 2020

Oncogenic EGFR signaling networks in glioma

1 reference

12 December 2020

Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas

1 reference

12 December 2020

The Cancer Biomedical Informatics Grid (caBIG): pioneering an expansive network of information and tools for collaborative cancer research

1 reference

12 December 2020

Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.

1 reference

12 December 2020

10.1038/NRNEUROL.2011.100

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

Dimensions Publication ID

14 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6980233&resulttype=core&format=json

14 May 2020

PubMed publication ID

21727940

1 reference